Federal contractor · public award history
VENATORX PHARMACEUTICALS INC
Parent: VENATORX PHARMACEUTICALS INC MBBKNBU5DCC6
- Awards we know about
- 4
- Typical size
- $60.36M
- Middle of their public awards
- Dollars on those awards
- $252.95M
Most of their awards we can see fall roughly between $42.69M and $87.20M.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Public award activity by year
Sum of award values in our USAspending index (not a full financial history).
- 2024$72.14M
- 2025$205.99M
Awarding agencies
- Department of Health and Human Services (4)
Industries & product codes
Award history
- Department of Health and Human Services$48.58M
IGF::OT::IGF - ORALLY BIOAVAILABLEβ-LACTAM/β-LACTAMASE INHIBITOR COMBINATION FOR BIODEFENSE AND PUBLIC HEALTH.
- Department of Health and Human Services$132.37M
VENATORX PHARMACEUTICALS, INC.
- Department of Health and Human Services$25.04M
TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
- Department of Health and Human Services$72.14M
VENATORX PHARMACEUTICALS: ANTIBIOTIC FOR AMR AND BIOTHREAT PATHOGENS
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.